Morgan Stanley’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-18,017
| Closed | -$24K | – | 8392 |
|
|
2021
Q4 | $24K | Sell |
18,017
-387,882
| -96% | -$517K | ﹤0.01% | 7155 |
|
|
2021
Q3 | $1.18M | Sell |
405,899
-792,311
| -66% | -$2.31M | ﹤0.01% | 4946 |
|
|
2021
Q2 | $4.18M | Buy |
1,198,210
+1,083,562
| +945% | +$3.78M | ﹤0.01% | 3972 |
|
|
2021
Q1 | $392K | Sell |
114,648
-432,719
| -79% | -$1.48M | ﹤0.01% | 5293 |
|
|
2020
Q4 | $10.5M | Buy |
547,367
+545,634
| +31,485% | +$10.5M | ﹤0.01% | 2461 |
|
|
2020
Q3 | $23K | Sell |
1,733
-9,095
| -84% | -$121K | ﹤0.01% | 6018 |
|
|
2020
Q2 | $458K | Sell |
10,828
-57,306
| -84% | -$2.42M | ﹤0.01% | 4646 |
|
|
2020
Q1 | $1.88M | Sell |
68,134
-54,197
| -44% | -$1.5M | ﹤0.01% | 3423 |
|
|
2019
Q4 | $3.97M | Sell |
122,331
-37,113
| -23% | -$1.2M | ﹤0.01% | 3446 |
|
|
2019
Q3 | $4.15M | Buy |
159,444
+58,915
| +59% | +$1.53M | ﹤0.01% | 3071 |
|
|
2019
Q2 | $3.69M | Sell |
100,529
-31,139
| -24% | -$1.14M | ﹤0.01% | 3234 |
|
|
2019
Q1 | $2.91M | Buy |
131,668
+41,598
| +46% | +$920K | ﹤0.01% | 3251 |
|
|
2018
Q4 | $1.27M | Buy |
90,070
+77,963
| +644% | +$1.1M | ﹤0.01% | 4105 |
|
|
2018
Q3 | $235K | Sell |
12,107
-2,486
| -17% | -$48.3K | ﹤0.01% | 5379 |
|
|
2018
Q2 | $322K | Sell |
14,593
-506
| -3% | -$11.2K | ﹤0.01% | 5344 |
|
|
2018
Q1 | $320K | Buy |
15,099
+11,581
| +329% | +$245K | ﹤0.01% | 5248 |
|
|
2017
Q4 | $88K | Buy |
+3,518
| New | +$88K | ﹤0.01% | 5675 |
|